Comparing the current results to its competitors, Vicarious Surgical Inc reported Revenue decrease in the 1 quarter 2026 year on year by 0 %, despite the revenue increase by the most of its competitors of 9.37 %, recorded in the same quarter.
Vicarious Surgical Inc, slower than the average decrease reported by the company's competitors of -37.47 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -37.47 %
Vicarious Surgical Inc's Comment on Competition and Industry Peers
The competitive landscape includes companies such as CMR Surgical Ltd. and other firms with significant experience in industrial robotics that may expand into surgical robotics. Research involving computers and robotics in surgery is ongoing at various companies and research institutions. The company has not yet established a sales or product distribution infrastructure for the Vicarious Surgical System and plans to enter the U.S. market through strategic partnerships, with the potential to develop its own sales force or distribution channels. Competitors announcing intentions to enter these markets may affect the company's future revenue as customers anticipate competing products.
April 12, 2025
Vicarious Surgical Inc. a robotics technology company based in Waltham, Massachusetts, is navigating significant challenges following a notice from the New York Stock Exchange (NYSE) relating to its compliance with listing standards. On April 10, 2025, the NYSE issued a written notice indicating that Vicarious Surgical was no longer aligned with the continued listing requirements specified under Section 802.01B of the exchange.This compliance notice raises concerns about the company s operational stability and highlights potential challenges in an increasingly competitive market. The NYSE standards, which aim to ensure transparency and accountability among listed companies, serve as a critical benchmark for ...
Medtronic Plc operates a global business model centered on the development and distribution of advanced medical technologies across four key segments: Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies, and Diabetes. The company emphasizes innovation and collaboration with healthcare providers to enhance patient outcomes and drive efficiency within healthcare systems.
Medinotec Inc is a medical technology company that operates on a business model focused on developing and providing innovative healthcare solutions, such as medical devices and software, to improve patient care and outcomes. Their products and services cater to healthcare professionals and institutions, offering advanced technology solutions in the medical field.
Johnson & Johnson operates as a multinational healthcare company with a diversified business model that spans pharmaceuticals, medical devices, and consumer health products. By focusing on innovation and strategic acquisitions, the company aims to improve global health and well-being.
Intuitive Surgical Incs business model focuses on delivering robotic surgical systems, particularly the da Vinci Surgical System, which facilitates minimally invasive surgeries. Revenue is generated through system sales, instruments, accessories, and services, including training and maintenance for healthcare providers.
Sources:
Vicarious Surgical Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Vicarious Surgical Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
